How reliable are ICER's results published in current pharmacoeconomic literature? The controversial issue of price confidentiality
{{output}}
Pharmacoeconomic data are widely used along drug life cycle for supporting decision-making processes on research and development, pricing and reimbursement, and market access. In this context, the incremental cost-effectiveness ratio (ICER) is the gold standar... ...
